NO20043371L - Kortikotropinfrigjorendefaktorreseptor-2 agonister - Google Patents

Kortikotropinfrigjorendefaktorreseptor-2 agonister

Info

Publication number
NO20043371L
NO20043371L NO20043371A NO20043371A NO20043371L NO 20043371 L NO20043371 L NO 20043371L NO 20043371 A NO20043371 A NO 20043371A NO 20043371 A NO20043371 A NO 20043371A NO 20043371 L NO20043371 L NO 20043371L
Authority
NO
Norway
Prior art keywords
corticotropin
releasing factor
agonists
factor receptor
receptors
Prior art date
Application number
NO20043371A
Other languages
English (en)
Inventor
Robert Joseph Isfort
Adam Wieslaw Mazur
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20043371L publication Critical patent/NO20043371L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57509Corticotropin releasing factor [CRF] (Urotensin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Isolerte derivater av den kortikotropinfrigj ørende faktor, og nukleinsyrer som koder disse, er effektive for å behandle forstyrrelser, så som muskeldystrofi, som modulereres av reseptorer av den kortikotropinfrigj ørende faktor 2.
NO20043371A 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister NO20043371L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19
PCT/US2003/001451 WO2003062268A2 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number Publication Date
NO20043371L true NO20043371L (no) 2004-10-06

Family

ID=27617822

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043371A NO20043371L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Country Status (30)

Country Link
US (7) US7192924B2 (no)
EP (4) EP1465921B1 (no)
JP (3) JP4508649B2 (no)
KR (3) KR100758858B1 (no)
CN (3) CN1617887A (no)
AR (3) AR038142A1 (no)
AT (4) ATE334147T1 (no)
AU (2) AU2003205197B2 (no)
BR (3) BR0306826A (no)
CA (3) CA2470731C (no)
CY (1) CY1106133T1 (no)
DE (4) DE60313845T2 (no)
DK (2) DK1465923T3 (no)
ES (4) ES2269976T3 (no)
HK (1) HK1078095A1 (no)
IL (5) IL162431A0 (no)
MA (3) MA27591A1 (no)
MX (3) MXPA04006885A (no)
MY (1) MY140306A (no)
NO (3) NO20043366L (no)
NZ (3) NZ533598A (no)
PE (3) PE20030974A1 (no)
PL (3) PL373529A1 (no)
PT (2) PT1465921E (no)
RU (1) RU2294333C2 (no)
SA (3) SA03230564B1 (no)
SI (1) SI1465921T1 (no)
TW (3) TWI300442B (no)
WO (3) WO2003062269A2 (no)
ZA (1) ZA200404995B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040049009A1 (en) * 2000-09-22 2004-03-11 Klaus Eckart Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US7192924B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
US20100034822A1 (en) * 2005-03-30 2010-02-11 Vega Masignani Haemophilus Influenzae Type B
US7815905B2 (en) 2006-01-27 2010-10-19 Research Development Foundation Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
KR20100056507A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys의 용도
RU2010114038A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение адреномедуллина в качестве терапевтического средства для лечения избыточного ангиогенеза
EA201170647A1 (ru) * 2008-11-04 2011-12-30 Янссен Фармацевтика Нв Пептиды-агонисты crhr2 и их использование
EP2206726A1 (en) * 2009-01-08 2010-07-14 Universite Joseph Fourier Non-invasive tools for detecting vulnerable atherosclerotic plaques
MX2012005262A (es) * 2009-11-04 2012-09-28 Janssen Pharmaceutica Nv Metodo para tratar la insuficiencia cardiaca con petidos tipo estrescopina.
US9314506B2 (en) 2011-10-24 2016-04-19 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
AU2013221615B2 (en) * 2012-02-14 2018-02-22 The Regents Of The University Of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
AU2017345785A1 (en) 2016-10-20 2019-05-16 Cortene Inc. Methods of treating diseases resulting from a maladapted stress response
CN110755434B (zh) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 化合物palosuran防治骨骼肌萎缩等疾病的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
EP0860501A3 (en) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin-releasing factor2 receptors
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US5824771A (en) * 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5663292A (en) 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
WO1997000063A2 (en) 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
EP1305334B1 (en) 2000-08-04 2008-09-17 Research Development Foundation Urocortin proteins and uses thereof
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7192924B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
PL373529A1 (en) 2005-09-05
US7462597B2 (en) 2008-12-09
BR0306878A (pt) 2004-10-26
CA2470656A1 (en) 2003-07-31
CN100391972C (zh) 2008-06-04
US20060025339A1 (en) 2006-02-02
KR100758857B1 (ko) 2007-09-14
US7608701B2 (en) 2009-10-27
US20030148956A1 (en) 2003-08-07
IL162529A0 (en) 2005-11-20
DE60313845T2 (de) 2008-01-31
ATE362488T1 (de) 2007-06-15
NO20043366L (no) 2004-10-06
AU2003237419B2 (en) 2006-04-13
US20100197579A1 (en) 2010-08-05
DK1465921T3 (da) 2006-11-27
PT1465921E (pt) 2006-12-29
ES2299701T3 (es) 2008-06-01
CN1617886A (zh) 2005-05-18
MA27590A1 (fr) 2005-11-01
DE60307044D1 (de) 2006-09-07
WO2003062269A2 (en) 2003-07-31
EP1724283B1 (en) 2008-06-18
IL196384A0 (en) 2011-07-31
KR20040082392A (ko) 2004-09-24
US7632933B2 (en) 2009-12-15
NZ533598A (en) 2007-03-30
WO2003062268A3 (en) 2003-11-27
SA03230565B1 (ar) 2006-10-31
MY140306A (en) 2009-12-31
EP1724283A3 (en) 2007-04-11
MA27592A1 (fr) 2005-11-01
KR20040082389A (ko) 2004-09-24
PL371364A1 (en) 2005-06-13
JP4508648B2 (ja) 2010-07-21
KR20040082390A (ko) 2004-09-24
CA2470743A1 (en) 2003-07-31
EP1465923B1 (en) 2007-05-16
DE60321730D1 (de) 2008-07-31
JP4489434B2 (ja) 2010-06-23
TW200302276A (en) 2003-08-01
TW200302277A (en) 2003-08-01
CN100475844C (zh) 2009-04-08
NO20043396L (no) 2004-10-06
WO2003062277A1 (en) 2003-07-31
BR0306838A (pt) 2005-04-05
AR038142A1 (es) 2004-12-29
EP1465923A1 (en) 2004-10-13
SA03230564B1 (ar) 2006-10-31
AU2003205197B2 (en) 2006-03-02
PE20030974A1 (es) 2003-12-26
NZ533600A (en) 2007-02-23
ATE398632T1 (de) 2008-07-15
AR038143A1 (es) 2004-12-29
JP2005522191A (ja) 2005-07-28
PL373139A1 (en) 2005-08-22
MXPA04006885A (es) 2004-12-06
JP2005521387A (ja) 2005-07-21
JP2005525101A (ja) 2005-08-25
CA2470731C (en) 2011-06-21
ES2309909T3 (es) 2008-12-16
CN1617887A (zh) 2005-05-18
HK1078095A1 (en) 2006-03-03
PE20030849A1 (es) 2003-12-01
IL162530A0 (en) 2005-11-20
US7897731B2 (en) 2011-03-01
US7192923B2 (en) 2007-03-20
WO2003062268A2 (en) 2003-07-31
BR0306826A (pt) 2005-09-06
WO2003062269A3 (en) 2003-11-06
ZA200404995B (en) 2005-06-29
PT1465923E (pt) 2007-08-06
SI1465921T1 (sl) 2006-10-31
DK1465923T3 (da) 2007-07-02
IL197774A0 (en) 2009-12-24
ATE334147T1 (de) 2006-08-15
TW200302278A (en) 2003-08-01
NZ533599A (en) 2007-03-30
MA27591A1 (fr) 2005-11-01
ES2269976T3 (es) 2007-04-01
EP1465922B1 (en) 2008-01-09
CA2470731A1 (en) 2003-07-31
US20080004435A1 (en) 2008-01-03
IL162431A0 (en) 2005-11-20
US20030148958A1 (en) 2003-08-07
SA03230564A (ar) 2005-12-03
EP1465921A2 (en) 2004-10-13
PE20030747A1 (es) 2003-10-23
US7192924B2 (en) 2007-03-20
RU2294333C2 (ru) 2007-02-27
CA2470743C (en) 2011-12-13
ATE383372T1 (de) 2008-01-15
CA2470656C (en) 2011-06-28
MXPA04006883A (es) 2004-12-06
CN1617885A (zh) 2005-05-18
DE60307044T2 (de) 2007-02-15
ES2287484T3 (es) 2007-12-16
MXPA04006884A (es) 2004-12-06
CY1106133T1 (el) 2011-06-08
EP1465921B1 (en) 2006-07-26
DE60318547T2 (de) 2008-12-24
SA03230565A (ar) 2005-12-03
KR100735586B1 (ko) 2007-07-04
KR100758858B1 (ko) 2007-09-14
EP1724283A2 (en) 2006-11-22
US6936585B2 (en) 2005-08-30
EP1465922A2 (en) 2004-10-13
DE60318547D1 (de) 2008-02-21
DE60313845D1 (de) 2007-06-28
US20090124793A1 (en) 2009-05-14
AR038144A1 (es) 2004-12-29
JP4508649B2 (ja) 2010-07-21
TWI300442B (en) 2008-09-01
RU2004124847A (ru) 2005-04-20
US20030148957A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
NO20043371L (no) Kortikotropinfrigjorendefaktorreseptor-2 agonister
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
DE602004016158D1 (de) 3-substituierte 5,6-diaryl-pyrazin-2-carbonsäureamid- und -2-sulfonsäureamidderivative als cb1 modulatoren
WO2005005462A3 (en) Blys antagonists and uses thereof
AU2002340010A1 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
WO2004022714A3 (en) Organic species that facilitate charge transfer to or from nanostructures
RS20050810A (en) 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
NO20091976L (no) Nye forbindelser
ATE533365T1 (de) Herabsetzung von tabakbestandteilen
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
NO20042926L (no) Indolinonderivater nyttige sorn proteinkinaseinhibitorer
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
CY1107196T1 (el) Υποκατεστημενα παραγωγα 2,4-διϋδρο-πυρρολο (3,4-β) -κινολιν-9-ονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
NO20071378L (no) Tiazolo-naftylsyrer.
GB0327380D0 (en) Method
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
NO20082849L (no) Behandlingsfluid for underjordisk formasjon omfattende zeolitt samt fremgangsmate ved behandling av en underjordisk formasjon
NO20045025L (no) Nye forbindelser
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
CY1105345T1 (el) Φαινυλαλκινια
MX2007004893A (es) Metodos y composiciones para el tratamiento de leucemia linfocitica cronica.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application